Xenetic Biosciences, Inc. (XBIO) stock
XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3069% below fair value
$1.40−0.14 (-9.09%)
Close on Nov 20, 2026Market cap $3.28MP/E –Yield –
Xenetic Biosciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Xenetic Biosciences's shares outstanding was 2M at Jun 30, 2026. For fiscal 2025 it was 2M, up 10.4% from the year before. Over ten years it grew 47.4% a year on average. The highest annual figure on record is 2M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2M | +10.4% |
| FY2024 | Dec 31, 2024 | 2M | +0.9% |
| FY2023 | Dec 31, 2023 | 2M | +7.4% |
| FY2022 | Dec 31, 2022 | 1M | +38.4% |
| FY2021 | Dec 31, 2021 | 1M | +60.8% |
| FY2020 | Dec 31, 2020 | 1M | +124.1% |
| FY2019 | Dec 31, 2019 | 0M | +277.3% |
| FY2018 | Dec 31, 2018 | 0M | +4.7% |
| FY2017 | Dec 31, 2017 | 0M | +16.6% |
| FY2016 | Dec 31, 2016 | 0M | +75.9% |
| FY2015 | Dec 31, 2015 | 0M | +2.6% |
| FY2014 | Dec 31, 2014 | 0M | +13.4% |
| FY2013 | Dec 31, 2013 | 0M | +0.0% |
| FY2012 | Dec 31, 2012 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 2M | +48.8% |
| Q1 FY2026 | Mar 31, 2026 | 2M | +48.6% |
| Q4 FY2025 | Dec 31, 2025 | 2M | +41.4% |
| Q3 FY2025 | Sep 30, 2025 | 2M | +0.0% |
| Q2 FY2025 | Jun 30, 2025 | 2M | +0.1% |
| Q1 FY2025 | Mar 31, 2025 | 2M | +0.1% |
| Q4 FY2024 | Dec 31, 2024 | 2M | +0.2% |
| Q3 FY2024 | Sep 30, 2024 | 2M | +0.6% |
| Q2 FY2024 | Jun 30, 2024 | 2M | +1.1% |
| Q1 FY2024 | Mar 31, 2024 | 2M | +1.6% |
| Q4 FY2023 | Dec 31, 2023 | 2M | +9.4% |
| Q3 FY2023 | Sep 30, 2023 | 2M | +14.0% |
| Q2 FY2023 | Jun 30, 2023 | 2M | +13.4% |
| Q1 FY2023 | Mar 31, 2023 | 2M | +49.2% |
| Q2 FY2022 | Jun 30, 2022 | 1M | +60.8% |
| Q1 FY2022 | Mar 31, 2022 | 1M | +53.7% |
| Q4 FY2021 | Dec 31, 2021 | 1M | +99.2% |
| Q3 FY2021 | Sep 30, 2021 | 1M | +61.4% |
| Q2 FY2021 | Jun 30, 2021 | 1M | +39.1% |
| Q1 FY2021 | Mar 31, 2021 | 1M | +40.3% |
| Q4 FY2020 | Dec 31, 2020 | 1M | +74.8% |
| Q3 FY2020 | Sep 30, 2020 | 1M | +613.8% |
| Q2 FY2020 | Jun 30, 2020 | 1M | +679.2% |
| Q1 FY2020 | Mar 31, 2020 | 1M | +694.9% |
| Q3 FY2019 | Sep 30, 2019 | 0M | +392.8% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +21.0% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +11.1% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +7.9% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +7.9% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +0.5% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +2.3% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +4.8% |
| Q3 FY2017 | Sep 30, 2017 | 0M | -3.0% |
| Q2 FY2017 | Jun 30, 2017 | 0M | +11.6% |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
| Q2 FY2016 | Jun 30, 2016 | 0M | – |
See a number that looks wrong?